JAMES P HALPER
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry NARROWSBURG, NY NPI 1922094366
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry NY Allergan Inc. All categories
General Payments — all program years on this page
$2,065.25
- Category: General Payments
- Program years: PY2018–2020
- Record count: 53
- As of (CMS publication): 2026-01-23
Latest program year (PY2020): $294.29 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2020) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $230.00 | 4 |
| Food and Beverage | $64.29 | 4 |
By paying entity
Latest program year (PY2020) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Allergan Inc. | $192.74 | 5 |
| Janssen Pharmaceuticals, Inc | $46.00 | 1 |
| Neurocrine BioSciences, Inc. | $28.82 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.73 | 1 |
By program year
Records — PY2020 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 719185239 | Janssen Pharmaceuticals, Inc | $46.00 | 07/09/2020 | Education | Undisputed | 01/23/2026 | View at CMS |
| 723305041 | Allergan, Inc. | $6.15 | 02/25/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 723305043 | Allergan, Inc. | $42.00 | 07/02/2020 | Education | Undisputed | 01/23/2026 | View at CMS |
| 723305045 | Allergan, Inc. | $51.00 | 07/02/2020 | Education | Undisputed | 01/23/2026 | View at CMS |
| 723305047 | Allergan, Inc. | $91.00 | 07/02/2020 | Education | Undisputed | 01/23/2026 | View at CMS |
| 723305049 | Allergan, Inc. | $2.59 | 11/13/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 747187617 | Takeda Pharmaceuticals U.S.A., Inc. | $26.73 | 01/27/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 748923921 | Neurocrine Biosciences, Inc. | $28.82 | 02/04/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.